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ABSTRACT 
In the present study synthetic α-alumina and calcium phosphate based composites were 
processed and their mechanical properties were characterized. α-Alumina nano-powder was 
synthesized using reverse micelle method. Calcium phosphate nano-powders with different 
molar ratio starting from 1.8 to 1.1 was synthesized by precipitation method, using calcium 
nitrate (Ca(NO3)2.4H2O) and ammonium dihydrogen orthophosphate (NH4H2PO4) as 
precursor materials as source for calcium (Ca²
+
) and phosphate ((PO4)
3-
) ions respectively. 
Then 5, 10, 20 weight % of Calcium phosphate powder was mixed with alumina, 
consolidated and sintered at 1400°C for 4 hours. The synthesized composites, in form of 
pellets were characterized for bulk density, apparent porosity, hardness and flexural strength 
and its grain size and morphology were studied from SEM micrographs of sintered pellets. 
The synthesized composites were found to have a bulk density in the range 3.092 – 3.76 g/cc, 
apparent porosity in the range 11-20% and hardness in the range 193.3 - 335 HV. 
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CHAPTER 1 
INTRODUCTION 
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For the last 40 years, ceramics materials are increasingly being used for the repair and 
reconstruction of skeletal diseases and disorders. The term bioceramics are being used for 
those manmade materials which are being used as medical implant and exhibit specific 
positive response within the body aimed for the repair or augmentation of damaged tissue 
and/or skeletal parts. These bioceramic materials particularly calcium phosphate based 
materials are being preferred mainly as bone substitute or scaffolds due to its 
biocompatibility, better bone and tissue bonding ability, and its compositional similarity with 
the inorganic components of human bone. Many of these bioceramic materials also possess 
excellent chemical resistance, compressive strength and wear resistance. However, there are 
some bioceramic materials which are inert in their bioactive response. This implies that the 
“bioinert” biomaterials lacks strong bond at the interface between the implant and the host 
tissue and are bonded through a fibrous capsule of non-adhering tissue. 
Calcium phosphate based ceramics has a wide range of composition where phases are either 
bio-active or bio-resorbable and hence finds wide range application in repairing 
masculoskeletal disorder as well as bone augmentation in defect or diseased side of human 
body. Calcium phosphate-based materials have attracted considerable interest in orthopaedic 
and dental applications because of their biocompatibility and tight bonding to bone, resulting 
in the growth of healthy tissue directly onto their surface. Among them, Apatite has been 
investigated as an alternative biomedical material. Apatite has also been considered as an 
attractive material for its similarity in structure and composition to bone. In vitro studies have 
shown that apatite is biocompatible, has a better stability and ensures the formation of a 
mechanically and functionally strong bone. However, the mechanical properties of apatite 
and all other calcium phosphates are generally inadequate for many load-carrying 
applications. These bioceramics have a low density, decreasing the mechanical properties of 
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the implant. Several combinations between calcium phosphate and other compounds have 
been proposed in order to improve the poor mechanical properties of calcium phosphate. 
Alumina (α-Al2O3) was the first bioceramic widely used clinically. It is used in load-bearing 
hip prostheses and dental implants because of its combination of excellent corrosion 
resistance, good biocompatibility, high wear resistance and high strength. Alumina is 
reported to be bio-inert until its grain size is in nano scale. 
The aim of this work was to elaborate a dense material having adequate mechanical 
properties to be used essentially as dental implants. Implants present the quality of auto-
protection against caries proliferation.  
This work focuses on preparing biphasic Calcium phosphate - α –Alumina composites, to 
investigate on the sintering behaviour and as a whole is to characterize the physical and 
mechanical properties of the nano composite. 
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CHAPTER 2 
LITERATURE REVIEW 
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2.1 Scope of Ceramic Biomaterials: 
Only a few of the materials known satisfy the requirements of implantation in the body. 
These biomaterials belong to all 5 major classes of materials: metals, ceramics, polymers, 
composites and natural materials. Wide diversity of these materials used in medicine is a 
result of materials research done in the last 50 years by controlling the composition, purity, 
physical properties of the materials and synthesizing new materials with new and special 
properties. These biomaterials are tailored according to the needs of medical devices such as 
woven polymer fibers in vascular grafts, bundles of cellulose acetate fibers in artificial kidney 
dialyzers, and titanium alloys in hip replacements [1]. The common property of all the 
biomaterials is biocompatibility or non-toxicity which is the definition of a material that is 
not recognized by the body as a potentially harmful foreign substance. Body can react 
instantly to a foreign material by the cells in body fluid and start an inflammation reaction 
followed by a wound healing process. Once an implant is placed in the body, an injury 
response is initiated by the tissue that results in inflammation as a reaction to local injury. 
Injury at the implant site leads to immediate development of the provisional matrix which 
consists of fibrin and inflammatory products released by the activated platelets, inflammatory 
cells and endothelial cells. Not all biocompatible materials are inert in the body but the highly 
bioactive ones incorporate to the actions of body like providing a host matrix for tissue 
growth or being slowly replaced by the growing tissue. Biocompatible materials are classified 
as bioinert, resorbable and bioactive according to tissue response. Bioinert materials induce 
formation of a fibrous tissue of variable thickness, interfacial bond forms on bioactive 
materials, and resorbable materials are replaced by the surrounding tissue [1]. Materials 
capable of evading attack by the body's immune system, and of stimulating tissue growth, are 
potentially far more effective and less costly. Mechanical similarity of the biomaterial to the 
host or replaced tissue is another important property. Especially in hard tissue replacements 
6 | P a g e  
 
the biomaterial is required to support or share a portion of the load. Compressive strength, 
fracture toughness and hardness of biomaterials are important in these cases. 
 
2.2 Bioceramics: 
Ceramics materials in form of oxides are the most commonly used and also found in great 
quantities in nature. The chemical synthesis, shaping and heat treatment processes of oxides 
are relatively simple compared to other materials. The properties common to all ceramics are 
chemical stability, low density, high hardness, low tensile strength and high compressive 
strength. Ceramics are ideal materials for mobile load bearing components in aggressive 
environments such as engine blocks, refractories and hard tissue replacements. Body is an 
active system regularly maintaining itself with its defense mechanism for optimum working 
conditions. A continuous process of building up and breaking down biostructures provides a 
demanding aggressive environment for body components. The actions of living cells as a part 
of the immune system are on the nanoscale and are basically chemical dissolution and 
adsorption processes. Following contact with body tissue, bare surface of a biomaterial is 
covered rapidly with proteins that are adsorbed from the surrounding body fluids. The 
chemistry of the underlying substrate, due to its effect on wettability and surface charge, 
controls the nature of the adherent protein layer. Macrophage fusion and platelet adhesion are 
strongly dependent on surface chemistry [1]. Although cells are able to adhere, spread and 
grow on bare biomaterial surfaces in vitro, proteins adsorbed from the adjacent tissue 
environment and adherent cells enhance cell attachment, migration and growth. Cell adhesion 
to biomaterials is mediated by cytoskeletal associated receptors in the cell membrane which 
interact with cell adhesion proteins that adsorb to the material surface from the surrounding 
plasma. The chemical nature of a biomaterial placed in the body as an implant therefore is 
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important in functioning of the body. Some ceramics that have been tested in vivo do not 
cause increased activity of immune system when dissolved in body fluid or in contact with 
tissues. Such ceramics, mainly oxides, are termed bioceramics. Bioceramics have the 
advantage of being compatible with the human body environment. Their biocompatibility is a 
direct result of their chemical compositions which contain ions commonly found in the 
physiological environment such as Ca
2+
, K
+
, Mg
2+
, Na
+
, and of other ions showing very 
limited toxicity to body tissues (such as Al
3+
 and Ti
2+
). Due to their excellent tribological 
properties and with their improved fracture toughness and reliability, structural ceramics such 
as polycrystalline alumina and has been used as hard tissue replacement materials . One 
remarkable success of bioceramics as implant materials over the last two decades has been 
the emergence and clinical use of bioactive ceramics that elicit a specific biological response 
at the interface of the material resulting in the formation of a strong bond between the tissue 
and the material. These bioceramics include calcium phosphates with hydroxyapatite being 
the prominent family member, Bioglasss, A-W glass–ceramic, and other bioactive glasses 
and glass–ceramics. However, the brittle nature of ceramics such as alumina and the low 
strength of bioactive ceramics such as hydroxyapatite have limited their scope of clinical 
applications. Bioceramics are generally used to repair or replace skeletal hard tissues and 
their stable attachment to connective tissue varies significantly. Bioceramics can be classified 
into four groups based on their type of attachment to the surrounding tissues. Dense and 
nearly inert ceramics attach to the bone by morphological fixation, or growth of bone into 
surface irregularities. Porous and inert ceramics are attached to the bone by ongrowth of the 
tissue or biological fixation. Dense and surface reactive ceramics attach directly by chemical 
bonding to the bone or bioactive fixation. Resorbable ceramics attach to the bone by any of 
the above mechanisms and are slowly replaced by bone. Examples to each of these types of 
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bioceramics are Al2O3, HA coated porous implants, hydroxyapatite, and tricalcium phosphate 
respectively. 
 
2.3 Alumina as a Bioceramic material: 
Biocompatible ceramics with mechanical properties comparable to metals are preferred in 
parts of the body that have high wear risk. An inert ceramic, alumina is used in load bearing 
hip prosthesis and dental implants in dense and pure state because of its excellent corrosion 
resistance, high strength and high wear resistance [9]. Alumina’s long term use in orthopedic 
surgery has been motivated by its excellent biocompatibility and very thin capsule formation 
which permits cementless fixation of prostheses as well as its very low coefficients of friction 
and wear. As a mechanically strong ceramic, alumina is also used as a reinforcing material in 
biocomposites. Clinical applications of alumina include knee prostheses, bone and dental 
screws, alveolar ridge and maxillofacial reconstruction, acicular bone substitutes, corneal 
replacements and segmental bone replacements. 
 
2.4 Calcium Phosphate based Bioceramic material: 
The main crystalline component of the mineral phase of bone is calcium deficient carbonate-
hydroxyapatite. Similarity of synthetic hydroxyapatite to bone mineral makes it the most 
clinically used biomaterial. Hydroxyapatite has a hexagonal symmetry and unit cell lattice 
parameters a = 0.95 nm and c = 0.68 nm. Taking into account the lattice parameters and its 
symmetry, its unit cell is considered to be arranged along the c-axis. This would justify a 
preferred orientation that gives rise to an oriented growth along the c-axis and a needle-like 
morphology [2]. Hydroxyapatite belongs to calcium phosphate class that is characteristically 
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resorbable in body. Tetracalcium Phosphate (Ca4P2O9), Amorphous calcium Phosphate, 
Tricalcium Phosphate (Ca3(PO4)2), and Hydroxyapatite (Ca10(PO4)6(OH)2) are members of 
calcium phosphates in order of decreasing solubility in body fluids. Unlike the other calcium 
phosphates, hydroxyapatite does not break down under physiological conditions. In fact, it is 
thermodynamically stable at physiological pH and actively takes part in bone bonding, 
forming strong chemical bonds with surrounding bone. For bone mimetic implants synthetic 
hydroxyapatite is produced by various methods. Hydroxyapatite is a thermally unstable 
compound, decomposing at temperatures from about 800-1200°C depending on its 
stoichiometry. The stoichiometry of hydroxyapatite is highly significant if thermal processing 
of the material is required [2]. Calcium phosphate phases of alpha and beta-tricalcium 
phosphate, tetracalcium phosphate occur with slight imbalances in the stoichiometric ratio of 
calcium and phosphorus in HA from the molar ratio of 1.67. It is also important to know the 
close relation between the stoichiometry, acidity and solubility. Thus, it is known that the 
lower the Ca/P ratio and the larger the acidity of the environment, the higher will be the 
solubility of the HA. For Ca:P < 1, both acidity and solubility are extremely high, and both 
parameters decrease substantially for Ca/P ratios close to 1.67, which is the value of 
stoichiometric hydroxyapatite [3]. The prevention of the formation of calcium phosphate 
phases with relatively higher solubility is significant when stability of hydroxyapatite is an 
important issue in the application. It is possible to sinter phase pure hydroxyapatite using 
stoichiometric composition at temperatures up to 1300°C. Hydroxyapatite lacks the 
mechanical strength required for long term use in biomedical implants [10]. In practice 
hydroxyapatite is either used as a bioactive coating on implants or reinforced by metal or 
ceramic phases. Several techniques have been utilized for the preparation of hydroxyapatite 
[2,3,5]. Materials with various morphology, stoichiometry, and level of crystallinity have 
been obtained depending on the technique. The synthetic routes employed can be divided into 
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solid-state reactions and wet methods, which include precipitation, hydrothermal and 
hydrolysis of other calcium phosphates. Modifications of these “classical” methods 
(precipitation, hydrolysis or precipitation in the presence of urea) or alternative techniques 
have been employed to prepare hydroxyapatite with morphology, stoichiometry, ion 
substitution or degree of crystallinity as required for a specific application. A stoichiometric 
and well crystallized product with low sinterability is obtained with wet methods but 
relatively high temperatures and long heat treatment times are required in synthesis [4]. 
Nanometer sized crystals can be obtained at temperatures lower than 100°C with 
precipitation techniques in the shape of needles, rods or equiaxed particles. Their crystallinity 
and stochiometry is close to well crystallized stoichiometric HA under precise control of 
preparation conditions. A common method of precipitation synthesis of HA is by using 
calcium nitrate and ammonium phosphate in the presence of ammonium hydroxide. 
Hydrothermal techniques give hydroxyapatite powders with a high degree of crystallinity and 
better stoichiometry having a wide distribution of crystal sizes. Applications of 
hydroxyapatite include surface coating of orthopedic and dental metal implants where HA 
both promote osteointegration process and reduce metal ion release by acting as a physical 
barrier; bioceramic preparation for replacements of bone fragments, repair of periodontal 
bony defects; and use as drug carrier for controlled drug release with promising potential to 
heal bone fractions and suppress inflammation process. Hydroxyapatite has been used 
clinically in different applications [2-3]. It has been utilized as a dense, sintered ceramic for 
middle ear implants, alveolar ridge reconstruction and augmentation, in porous form as 
granules for filling body defects in dental and orthopaedic surgery and as a coating on metal 
implants. 
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2.5 Preparation of Calcium Phosphate (Apatite): 
 Precipitation Method 
The precursors used are calcium nitrate tetrahydrate as the source of calcium and 
ammonium dihydrogen orthophosphate as the source of phosphate. Ammonia solution 
is used as precipitant and it is added to maintain a pH of 10. It has been reported that 
the hydroxyapatite prepared through this technique shows excellent mechanical 
properties. 
Ca(NO3)2.4H2O + NH4H2PO4 + NH4OH                             Ca10(PO4)6(OH)2 
 
 Hydrothermal method 
Calcium carbonate is used as the source for calcium and Ammonium dihydrogen 
orthophosphate is used as the source for phosphate. 
CaCO3 + NH4H2PO4                   Ca10(PO4)6(OH)2 + H2O + CO2 
 
 Solid State Synthesis 
The precursors used in the preparation of hydroxyapatite are calcium hydroxide as the 
source of calcium and phosphoric acid as the source of phosphate [5]. 
Ca(OH)2 + H3PO4  Ca10(PO4)6(OH)2 
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2.6 Preparation of α –Alumina: 
Nano sized alumina powders are prepared by Reverse Micelle process [6]. 
By stepwise hydrolysis, using aqueous ammonia as the precipitant, hydroxide precursor is 
obtained from nitrate solutions dispersed in nano sized aqueous domains of micro emulsion 
consisting of Cyclohexane as the oil phase, Triton-X as the non-ionic surfactant and aqueous 
solution containing Aluminium nitrate as the water phase. Butanol is taken as the co-
surfactant. 
Al(NO3)3.9H2O + NH4OH  Al(OH)3 + NH4NO3 
Now the precipitate is washed properly and then calcined at 1200°C to obtain α-alumina nano 
powder. 
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CHAPTER 3 
EXPERIMENTAL 
PROCEDURE 
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3.1 Preparation of Calcium Phosphate Powder: 
Calcium phosphate required in the study was prepared by precipitation method. Six 
different batches of calcium phosphate with varying Ca/P molar ratio (1.8, 1.67, 1.5, 1.33, 
1.21 and 1.1) were synthesized. Calcium nitrate (Ca(NO3)2.4H2O) and ammonium 
dihydrogen orthophosphate (NH4H2PO4) were taken as precursor materials as source for 
calcium (Ca²
+
) and phosphate ((PO4)
3-
) ions respectively. Ammonia solution was taken as the 
precipitant. 
Molar weight of Ca(NO3)2.4H2O = 236g 
Molar weight of NH4H2PO4 = 115g 
For synthesis of each batch, the required weight ratios of the precursor materials are taken. 
Ca/P Molar Ratio Weight ratio of 
(Ca(NO3)2.4H2O/ NH4H2PO4) 
taken for synthesis 
1.8 12.744 : 3.45 
1.67 11.823 : 3.45 
1.5 10.62 : 3.45 
1.33 9.416 : 3.45 
1.2 8.496 : 3.45 
1.1 7.788 : 3.45 
Table 3.1: Amount of precursors taken for synthesis of calcium phosphate nano powder with 
different Ca/P molar ratio 
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The amount of precursor materials taken are mixed properly and a solution is made. The PH 
of the solution is maintained at 10 by adding ammonia solution. The solution is stirred for 5-6 
hours and after that it is allowed to precipitate. Then the precipitate is washed thoroughly by 
distilled water by centrifugal process in the Centrifuge apparatus. 
Centrifuge cycle : 8000 rpm for 5 minutes 
Each sample is washed properly for 3 times. Then finally each sample is dried in Vacuum 
drier at 80°C for 24 hours. 
 
3.2 Preparation of α - Alumina Powder: 
Nano sized alumina powders were synthesized via Reverse Micelle process. 
200g of Aluminium nitrate (Al(NO3)3.9H2O) was taken in 400ml water. 2000ml Cyclohexane 
was added to the aluminium nitrate solution and properly stirred. Now surfactant, Triton-X 
was added drop wise with continued stirring until a translucent or milky solution is formed. 
Then equal amount of co-surfactant, Butanol was added. Now the pH of the solution is 
maintained at 10 by adding precipitant, ammonia solution. The solution is properly stirred 
and allowed to precipitate. The precipitate was washed with Propan-2-ol and filtered with 
Whatman-40 filter paper. 
Al(NO3)3.9H2O + NH4OH  Al(OH)3 + NH4NO3 
Now the filtrate is dried in Vacuum oven at 80°C and the dried powder is calcined at 1200°C 
to form alumina powder (Al2O3). 
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3.3 Preparation of Calcium phosphate –Alumina composites: 
5, 10, 20 weight % of Calcium phosphate powder (6 batches) was mixed with Alumina 
powder separately to form composites with different composition. Each batch of composite 
was added with 3% PVA binder and pressed to form 0.5g of pellets in a 12mm cylindrical 
die. The green pellets are pressed at 4 Tonn pressure and given a dwell time of 90 seconds. 
Now the green pellets were sintered at 1400°C with a soaking time of 4 hours. 
The firing cycle was composed of 500°C with soaking time 2 hours, for binder burn out and 
1400°C with 4 hours of soaking time, for sintering. 
 
3.4 Characterization: 
3.4.1 X-Ray Diffraction (XRD): 
The XRD of calcium phosphate and alumina powder synthesized were done using Philips X-
Ray diffractometer (PW 1730, Holland) with nickel filtered Cu Kα radiation (λ = 1.5406 A° ) 
at 40 kV and 30mA having a scan range(°2 θ) of 10-60° for calcium phosphate powder and 
10-80° for alumina powder, at a scan speed of 0.04 (°2 θ/sec). 
3.4.2 Particle Size Distribution Analysis: 
Very little amount of calcium phosphate powder from each batch was taken and six different 
solutions were made. The solution were then set for ultrasonication using an unltrasonic 
vibratometer. Ultrasonication was done for 10 minutes until all the agglomerates were broken 
down. Now the particle size distributions of the calcium phosphate present in those solutions 
were done by using Malvern Particle Size Analyser. 
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3.4.3 Bulk Density (BD) and Apparent Porosity (AP): 
The sintered pellets of the composite were immersed in water which was boiled for 3 hours 
until no vapours are seen coming out of the pellets. Now the dry, soaked and suspended 
weight of the pellets is calculated. 
Bulk Density is calculated by the formula: 
              
         
                            
                        
 
Apparent Porosity is calculated by the formula: 
                    
                      
                            
          
 
3.4.4 Vickers Hardness (HV): 
The sintered pellets of the composites were polished properly with Emery paper. Now the 
hardness of the pellets was measured by Vickers Hardness Tester. 
Here an indent was given on the pellet and the lens of the instrument was focussed on the 
diameter of the indent. 
Vickers hardness is given by the formula: 
HV = 1.854 * F/d² 
where F is the indent given, measured in (KgF) and d is mean diameter of the indent 
measured in (mm) 
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3.4.5 Bi-axial Flexural Strength: 
The diameter and thickness of the pellets were measured. Now the Bi-axial flexural strength 
of the pellets were measured by UTM machine. Here the pellets are kept on their width and a 
constant extension per time was fed in the instrument. The instrument measures the 
maximum load at fracture. 
Flexural strength is given by formula: 
                    
  
   
  
where F is the maximum load at fracture, d is diameter of the pellet and t is the thickness of 
the pellet 
 
 
 
 
 
 
 
 
 
 
19 | P a g e  
 
Sample no. Composition 
1 5% CaP (1.8) 95%Al2O3 
2 5% CaP (1.67) 95%Al2O3 
3 5% CaP (1.5) 95%Al2O3 
4 5% CaP (1.33) 95%Al2O3 
5 5% CaP (1.2) 95%Al2O3 
6 5% CaP (1.1) 95%Al2O3 
 1’ 10% CaP (1.8) 90%Al2O3 
 2’ 10% CaP (1.67) 90%Al2O3 
3’ 10% CaP (1.5) 90%Al2O3 
4’ 10% CaP (1.33) 90%Al2O3 
5’ 10% CaP (1.2) 90%Al2O3 
6’ 10% CaP (1.1) 90%Al2O3 
1’’ 20% CaP (1.8) 80%Al2O3 
2’’ 20% CaP (1.67) 80%Al2O3 
3’’ 20% CaP (1.5) 80%Al2O3 
4’’ 20% CaP (1.33) 80%Al2O3 
5’’ 20% CaP (1.2) 80%Al2O3 
6’’ 20% CaP (1.1) 80%Al2O3 
 
Table 3.2: Different composition of alumina-calcium phosphate composite 
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RESULTS  
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4.1 X-Ray Diffraction pattern of Calcium Phosphate Powders: 
The X-Ray Diffraction pattern of the six batches of synthesized calcium phosphate nano 
powders is shown in the figure 4.1. 
 
 
Fig 4.1: X-Ray Diffraction pattern for six batches of calcium phosphate 
The X-Ray Diffraction pattern of the six different batches of calcium phosphate synthesized 
using precipitation method, with varying Ca/P molar ratio, shows the presence of hydroxy 
apatite phase. 
4.2 Particle Size Analysis of Calcium Phosphate Powders: 
The particle size distribution of the six batches of calcium phosphate is given below in 
figures 4.2a to 4.2f. 
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Fig 4.2a: Particle size distribution of Ca/P ratio = 1.8 
 
 
Fig 4.2b: Particle size distribution of Ca/P ratio = 1.67 
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Fig 4.2c: Particle size distribution of Ca/P ratio = 1.5 
 
 
Fig 4.2d: Particle size distribution of Ca/P ratio = 1.33 
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Fig 4.2e: Particle size distribution of Ca/P ratio = 1.2 
 
 
Fig 4.2f:  Particle size distribution of Ca/P ratio = 1.1 
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The average particle size of the calcium phosphate nanopowders with Ca/P molar ratios 1.8, 
1.67, 1.5, 1.33, 1.2 and 1.1 were found to be 128.51nm, 127.60nm, 139.07nm, 142.92nm, 
150.33nm and 224.98nm respectively. The calcium phosphate nano powders with Ca/P molar 
ratio of 1.67 showed the lowest average particle size of 127.6 nm as shown in figure 4.2b and 
table 4.1. 
Ca/P Ratio Average Particle Size (nm) 
1.8 128.51 
1.67 127.60 
1.5 139.07 
1.33 142.92 
1.2 150.33 
1.1 224.98 
 
Table 4.1: Average particle size of different calcium phosphate powders 
 
4.3 X-Ray Diffraction Pattern of Alumina Powder: 
The X-Ray diffraction pattern of alumina powder calcined at 1200°C for 4hrs is shown in 
figure 4.3. 
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 Fig 4.3: X-ray diffraction pattern of alumina powder calcined at 1200°C for 4hrs 
The x-ray diffraction pattern of alumina powder synthesized using reverse micelle method 
and then calcined at 1200°C for 4hrs shows the presence of α-alumina. 
 
4.4 Bulk density of sintered composite: 
The bulk density distribution of the sintered calcium phosphate –alumina composite has been 
shown in figure 4.4a to 4.4c. The sample nos. 1, 2, 3, 4, 5 and 6 determines 5 weight % of 
CaP nano powder with different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 
respectively mixed with 95 weight % alumina powder as shown in figure 4.4a. Composition 
with Ca:P molar ratio of 1.67 showed the highest bulk density of 3.76 g/cc as shown in figure 
4.4a. 
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Fig 4.4a: Bulk density distribution for (5% CaP- 95% Al2O3) sintered composite 
 
Fig 4.4b: Bulk density distribution for (10% CaP- 90% Al2O3) sintered composite 
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The sample nos. 1, 2, 3, 4, 5 and 6 in figure 4.4b determines 10 weight % of CaP nano 
powder with different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 respectively mixed 
with 90 weight % alumina powder as shown in figure 4.4b. Composition with Ca:P molar 
ratio of 1.2 showed the highest bulk density of 3.43 g/cc as shown in figure 4.4b. 
 
Fig 4.4c: Bulk density distribution for (20% CaP -80% Al2O3) sintered composite 
The sample nos. 1, 2, 3, 4, 5 and 6 in figure 4.4c determines 20 weight % of CaP nano 
powder with different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 respectively mixed 
with 80 weight % alumina powder as shown in figure 4.4c. Composition with Ca:P molar 
ratio of 1.67 showed the highest bulk density of 3.198 g/cc as shown in figure 4.4c. 
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4.5 Apparent Porosity of Sintered Composite: 
The apparent porosity distribution of the sintered calcium phosphate –alumina composite has 
been shown in figure 4.5a to 4.5c. The sample nos. 1, 2, 3, 4, 5 and 6 determines 5 weight % 
of CaP nano powder with different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 
respectively mixed with 95 weight % alumina. Composition with Ca:P molar ratio of 1.67 
showed the lowest apparent porosity of 11% as shown in figure 4.5a. 
 
 
Fig 4.5a: Apparent porosity distribution for (5% CaP -95% Al2O3) sintered composite  
. The sample nos. 1, 2, 3, 4, 5 and 6 determines 10 weight % of CaP nano powder with 
different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 respectively mixed with 90 
weight % alumina. Composition with Ca:P molar ratio of 1.2 showed the lowest apparent 
porosity of 13.75% as shown in figure 4.5b. 
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Fig 4.5b: Apparent porosity distribution for (10% CaP- 90% Al2O3) sintered composite 
 
Fig 4.5c: Apparent porosity distribution for (20% CaP- 80% Al2O3) sintered composite 
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. The sample nos. 1, 2, 3, 4, 5 and 6 determines 20 weight % of CaP nano powder with 
different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 respectively mixed with 80 
weight % alumina. Composition with Ca:P molar ratio of 1.67 showed the lowest apparent 
porosity of 17% as shown in figure 4.5c. 
4.6 Hardness of Sintered Composites: 
The Vickers hardness distribution of the sintered calcium phosphate –alumina composite has 
been shown in figure 4.6a to 4.6c. The sample nos. 1, 2, 3, 4, 5 and 6 determines 5 weight % 
of CaP nano powder with different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 
respectively mixed with 95 weight % alumina. Composition with Ca:P molar ratio of 1.67 
showed the highest hardness of 335 HV as shown in figure 4.6a. 
 
Fig 4.6a: Hardness distribution for (5% CaP- 95% Al2O3) sintered composite 
The sample nos. 1, 2, 3, 4, 5 and 6 determines 10 weight % of CaP nano powder with 
different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 respectively mixed with 90 
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weight % alumina. Composition with Ca:P molar ratio of 1.2 showed the highest hardness of 
287.8 HV as shown in figure 4.6b. 
 
Fig 4.6b: Hardness distribution for (10% CaP- 90% Al2O3) sintered composite 
The sample nos. 1, 2, 3, 4, 5 and 6 determines 20 weight % of CaP nano powder with 
different Ca/P molar ratio i.e. 1.8, 1.67, 1.5, 1.33, 1.2 and 1.1 respectively mixed with 80 
weight % alumina. Composition with Ca:P molar ratio of 1.67 showed the highest hardness 
of 222.4 HV as shown in figure 4.6c. 
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Fig 4.6c: Hardness distribution for (20% CaP -80% Al2O3) sintered composite 
4.7 Bi-Axial Flexural Strength of Sintered Composites: 
The load vs extension curve for 5% CaP(1.67)- 95% Al2O3 compact is shown in figure 4.7a. 
 
Fig 4.7a: Bi-Axial Flexural strength for (5% CaP(1.67)- 95% Al2O3) sintered composite  
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The load vs extension curve for 10% CaP(1.67)- 90% Al2O3 compact is shown in 
figure 4.7b. 
 
Fig 4.7b: Bi-Axial Flexural strength for (10% CaP(1.67) -90% Al2O3) sintered 
composite 
The load vs extension curve for 10% CaP(1.8)- 90% Al2O3 compact is shown in figure 4.7c. 
 
Fig 4.7c: Bi-Axial Flexural strength for (10% CaP(1.8)- 90% Al2O3) sintered composite 
35 | P a g e  
 
The load vs extension curve for 20% CaP(1.67)- 80% Al2O3 compact is shown in 
figure 4.7d. 
 
Fig 4.7d: Bi-Axial Flexural strength for (20% CaP(1.67)- 80% Al2O3) sintered 
composite 
Bi-Axial Flexural strength of different sintered composites is shown in table 4.2. 
Sample 
No. 
Composite Bi-Axial Flexural Strength (MPa) 
2 5% CaP(1.67) 95% Al2O3 47.545 
1’ 10% CaP(1.8) 90% Al2O3 23.23 
2’ 10% CaP(1.67) 90% Al2O3 24.14 
2’’ 20% CaP(1.67) 80% Al2O3 19.84 
 
Table 4.2:  Bi-Axial Flexural strength of different sintered composites 
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4.8 SEM of sintered composites: 
SEM images of few sintered calcium phosphate –alumina composites are shown in figure 
4.8a to 4.8c. The SEM image for 5% CaP(1.8) -95% Al2O3 compact is shown in figure 4.8a. 
 
 
 
Fig 4.8a: SEM image of 5% CaP (1.8) -95% Al2O3 sintered composite 
 
The SEM image for 5% CaP(1.67) 95% Al2O3 compact is shown in figure 4.8b. 
 
Fig 4.8b: SEM image of 5% CaP (1.67) 95% Al2O3 sintered composite 
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The SEM image for 10% CaP(1.67) 90% Al2O3 compact is shown in figure 4.8c. 
 
 
Fig 4.8c: SEM image of 10% CaP (1.67) 90% Al2O3 sintered composite 
 
From the SEM images it is seen that, the average grain size of the sintered Calcium 
phosphate –Alumina composites is around 1µm and to some extent the microstructure shows 
open porosity in all the samples. 
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CHAPTER 5 
CONCLUSIONS & SCOPE 
OF FUTURE WORK 
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Alumina –calcium phosphate composites with different Ca/P moalr ratio and variation in 
weight % of Calcium phosphate and alumina from 5:95 to 20:80 were successfully 
processed and characterized. Particle size of calcium phosphate nanoparticles measured 
using dynamic light scattering (DLS) technique showed size distribution between 100 to 
200 nm. Calcium phosphate nanopowder with Ca/P ratio of 1.67 showed the lowest 
particle size of 127.6 nm.  The composition of 5 wt% CaP (1.67) and 95 wt% Al2O3 
showed the highest bulk density of 3.76 g/cc, the lowest porosity of 11%, the highest 
Vicker’s hardness of 335 HV and the highest flexural strength of 47.545 MPa. 
In-vitro bioactivity study using osteoblast cell line would be the next characterization step 
for all the alumina- calcium phosphate composites. 
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